Nucala 100 MG/ML auto-injectorml

Ended Awarded Last action

Contract number
SPE2DR26FGBT9
Awardee
Awarding agency
Obligated
$1,932

Award facts

Contract value 100% obligated
$1,931.83 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $1,931.83 delivery order to DMS Pharmaceutical Group Inc. on March 23, 2026, for Nucala 100 mg/mL auto-injector supply, with ultimate completion on March 24, 2026.

DMS Pharmaceutical Group Inc. is a woman-owned small business. The order was issued under the company's single-award Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion program authorized through December 31, 2036. Place of performance is Park Ridge, Illinois. The order carries firm fixed-price pricing and no set-aside designation.

Quick answers

Who was awarded contract SPE2DR26FGBT9?

SPE2DR26FGBT9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 23, 2026.

How much is contract SPE2DR26FGBT9 worth?

The government has obligated $1,932 on SPE2DR26FGBT9.

Is contract SPE2DR26FGBT9 an order under another contract?

Yes. SPE2DR26FGBT9 is a delivery order under SPE2DR25D9315, an indefinite delivery contract.

Was contract SPE2DR26FGBT9 competed?

The extent of competition for SPE2DR26FGBT9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award